Said Dermime

Research interests

Publications

• CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

  Molecular Cancer · 2023 · https://doi.org/10.1186/s12943-023-01723-z

• Chronic inflammation and cancer; the two sides of a coin

  Life Sciences · 2023 · https://doi.org/10.1016/j.lfs.2023.122390

• Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines

  Annals of Medicine · 2022 · https://doi.org/10.1080/07853890.2022.2031274

• Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer

  Journal of Experimental & Clinical Cancer Research · 2022 · https://doi.org/10.1186/s13046-022-02318-0

• Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

  Journal of Translational Medicine · 2020 · https://doi.org/10.1186/s12967-020-02306-y

• Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications

  Seminars in Cancer Biology · 2020 · https://doi.org/10.1016/j.semcancer.2020.08.009

• The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials

  Translational Lung Cancer Research · 2019 · https://doi.org/10.21037/tlcr.2019.08.09

• RAS-mediated oncogenic signaling pathways in human malignancies

  Seminars in Cancer Biology · 2018 · https://doi.org/10.1016/j.semcancer.2018.03.001

• NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

  Frontiers in Immunology · 2018 · https://doi.org/10.3389/fimmu.2018.00947

• Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products

  Molecular Cancer · 2018 · https://doi.org/10.1186/s12943-018-0788-y

• Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges

  Current Vascular Pharmacology · 2017 · https://doi.org/10.2174/1570161115666170105124038

• The immunoinhibitory B7-H1 molecule as a potential target in cancer

  Hematology/Oncology and Stem Cell Therapy · 2014 · https://doi.org/10.1016/j.hemonc.2013.09.005

• Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation

  Journal of Inflammation · 2012 · https://doi.org/10.1186/1476-9255-9-48

• Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

  Breast Cancer Research · 2010 · https://doi.org/10.1186/bcr2605

• Breast Carcinoma–Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes

  Cancer Research · 2008 · https://doi.org/10.1158/0008-5472.can-08-0192

• FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy

  BMC Cancer · 2008 · https://doi.org/10.1186/1471-2407-8-57

• Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells

  International Journal of Cancer · 2007 · https://doi.org/10.1002/ijc.22703

• The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors

  Neoplasia · 2006 · https://doi.org/10.1593/neo.05733

• Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells

  Blood · 1996 · https://doi.org/10.1182/blood.v88.7.2450.bloodjournal8872450

• Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

  Blood · 1993 · https://doi.org/10.1182/blood.v82.5.1573.1573

Current projects

No projects listed.